What is RPAP?
Who is eligible for assistance through RPAP?
What documentation is required?
What is the enrollment process?
Is there a need for re-enrollment?
What is RPAP?
The Renal Patient Assistance Program (RPAP) is designed for patients in financial need without coverage for Renvela® (sevelamer carbonate) and/or Hectorol® (doxercalciferol injection) under any prescription drug benefit, including commercial insurance, Medicare, Medicaid, or other government insurance programs.
Through partnership with the American Kidney Fund (AKF), Genzyme will provide qualifying patients with free medication.
Who is eligible for assistance through RPAP?
- Patients who do not have existing drug coverage for Renvela® and/or Hectorol under any prescription drug benefit, including commercial insurance, Medicare, Medicaid, or other government insurance programs.
- US citizens or legal residents:
- A copy of Green Card or Permanent Resident Card is required for legal residents.
- Patients in the 90-Day Waiting Period for Medicare coverage
- Financial eligibility is based on the patient’s monthly household income, expenses and total assets, and is determined by the American Kidney Fund (AKF).
- Please note: Effective January 1, 2012 – only Hectorol IV offered.
- The only formulations of Hectorol offered will be the 4 mcg/2mL vial and 2 mcg/mL vial
What documentation is required?
- A Renassist Insurance Verification Form & Patient Assistance Application must be completed and submitted to RenassistSM via fax or email to 877-363-6732 or PAP@genzyme.com.
- Medicare A and B beneficiaries having household income below 150% of the Federal Poverty Level (FPL) who are applying for Renvela or Hectorol assistance must include either the Official Notice of Denial or the Pre-Decisional Notice for the Limited Income Subsidy (LIS) from the Social Security Administration.
- If applicant is legal resident, a copy of the Green Card or Permanent Resident Card.
What is the enrollment process?
- All applications are submitted to Renassist for review of insurance status, and then forwarded to the AKF for financial review.
- You and/or your patient will be contacted by fax or phone if an application is incomplete or requires additional information.
- The AKF will send an Approval or Denial Letter to the dialysis unit by mail or email.
- Medication will be filled by Diplomat Pharmacy in up to a 3-month supply with a maximum of 3 refills through the RPAP Grant Approval Date for patients who continue to meet the program criteria
Is there a need for re-enrollment?
- Qualified applicants are required to re-apply one year from the date the prescription was written
- Should the patient or Health care provider have questions regarding the refill process please contact Renassist directly at 800-847-0069.
*If you do not have Adobe Reader version 9.0 or higher, be sure to save the application onto your desktop before electronically entering information to ensure that your work is captured and saved.